Dementia is characterized by progressive cognitive impairment and is the most frequent cause of death in the United States after heart disease, cancer and stroke. The most common cause of dementia is Alzheimer's disease (AD) but many other forms have been identified. Those dementias that have no clear distinguishing histological features remain largely unclassified. However, many dementias including AD exhibit familial clustering. Indeed some cases, particularly those with an early age of onset, show an autosomal dominant pattern of inheritance. Genetic linkage studies have already identified mutations causing Alzheimer's disease, Prion diseases and Huntington's disease. We propose to use a molecular genetic approach to further our understanding of the underlying causes of dementia. During the last twelve months we have identified several families multiply affected by adult onset (late and early onset) dementia. We are collecting family history , clinical and neuropathological information on these families and have begun to collect blood samples for linkage studies. In some of these families a diagnosis of Alzheimer's disease has been made whilst in others either there was no firm diagnosis or a diagnosis of another dementing illness was made. These dementing diseases may represent phenotypic variants of the known causes of dementia or genetically distinct disorders. Two of the families are multiply affected by hereditary dysphasic dementia (HDD), a cortical dementia of adult onset and autosomal dominant inheritance. Clinical and neuropathological investigations describe a unique phenotype that fits within the Pick- Alzheimer spectrum. We will use a genetic linkage strategy to test the known causes of dementia in these and other families e.g., mutations within the amyloid precursor protein (APP) gene and the prion protein gene and linkage to the chromosome 14 familial AD (FAD) locus and the Huntington's locus on chromosome 4. If linkage to the APP gene, the prion protein gene or the HD locus is detected, the gene will be sequenced to identify the mutation causing disease. Families showing linkage to the FAD locus on chromosome 14 will be used for other studies in our laboratory. If these causes of dementia can be excluded, a genetic linkage strategy will be used to map the disease loci. A positional cloning strategy will be used to clone the HDD gene. If the HDD locus is a novel gene, preliminary characterization of the gene and the gene product will be undertaken.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Specialized Center (P50)
Project #
3P50AG005681-16S1
Application #
6098083
Study Section
Project Start
1999-08-01
Project End
2000-04-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
16
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Washington University
Department
Type
DUNS #
062761671
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Kirson, Noam Y; Scott Andrews, J; Desai, Urvi et al. (2018) Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease. J Alzheimers Dis 61:295-307
Roe, Catherine M; Ances, Beau M; Head, Denise et al. (2018) Incident cognitive impairment: longitudinal changes in molecular, structural and cognitive biomarkers. Brain 141:3233-3248
La Joie, Renaud; Bejanin, Alexandre; Fagan, Anne M et al. (2018) Associations between [18F]AV1451 tau PET and CSF measures of tau pathology in a clinical sample. Neurology 90:e282-e290
Day, Gregory S; Musiek, Erik S; Morris, John C (2018) Rapidly Progressive Dementia in the Outpatient Clinic: More Than Prions. Alzheimer Dis Assoc Disord 32:291-297
Ihara, Ryoko; Vincent, Benjamin D; Baxter, Michael R et al. (2018) Relative neuron loss in hippocampal sclerosis of aging and Alzheimer's disease. Ann Neurol 84:741-753
Swarup, Vivek; Hinz, Flora I; Rexach, Jessica E et al. (2018) Identification of evolutionarily conserved gene networks mediating neurodegenerative dementia. Nat Med :
Sato, Chihiro; Barthélemy, Nicolas R; Mawuenyega, Kwasi G et al. (2018) Tau Kinetics in Neurons and the Human Central Nervous System. Neuron 97:1284-1298.e7
Sutphen, Courtney L; McCue, Lena; Herries, Elizabeth M et al. (2018) Longitudinal decreases in multiple cerebrospinal fluid biomarkers of neuronal injury in symptomatic late onset Alzheimer's disease. Alzheimers Dement 14:869-879
Bussy, Aurélie; Snider, B Joy; Coble, Dean et al. (2018) Effect of apolipoprotein E4 on clinical, neuroimaging, and biomarker measures in noncarrier participants in the Dominantly Inherited Alzheimer Network. Neurobiol Aging 75:42-50
Vardarajan, Badri N; Barral, Sandra; Jaworski, James et al. (2018) Whole genome sequencing of Caribbean Hispanic families with late-onset Alzheimer's disease. Ann Clin Transl Neurol 5:406-417

Showing the most recent 10 out of 952 publications